Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...
Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...
Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...
A doctor who diagnosed herself with stage four colon cancer has shared the two ‘mild’ symptoms she discovered. US -based ...
Kathy Bates explained her decision not to have reconstruction surgery after her 2012 breast cancer diagnosis and double ...
Researchers at the University of California San Diego are hoping to drastically shorten the time between a cancer diagnosis ...
Ovarian cancer is the sixth most common cancer in women in the UK but the symptoms can be quite subtle, often leaving to a ...
Hollywood star Kathy Bates has opened up about her experience with cancer and the surgery she endured to help her defeat the ...
In a world-first finding, Melbourne researchers investigated a major “blind spot” in cancer research and discovered how a ...
Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback